11/15/2024
4:25 PM | Galera Therapeutics (Filer)
| Form NT 10-Q | |
10/18/2024
7:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
6:38 AM | Galera Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/04/2024
6:01 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
6:00 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
08/23/2024
6:00 AM | Galera Therapeutics (Filer)
| Form PRE 14A | |
08/20/2024
3:45 PM | Galera Therapeutics (Issuer)
Sorensen Mel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/16/2024
11:52 AM | Galera Therapeutics (Subject)
Sorensen Mel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:10 AM | Galera Therapeutics (Subject)
| Form 425 | |
08/08/2024
6:00 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:02 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:00 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
9:25 AM | Galera Therapeutics (Subject)
Soffer Rochel (Filed by)
| Form SC 13G | |
05/16/2024
9:26 AM | Galera Therapeutics (Subject)
Schneid Yair (Filed by)
| Form SC 13G/A | |
05/16/2024
9:26 AM | ALPHA PHARMA Investments LLC (Reporting)
Galera Therapeutics (Issuer)
Soffer Rochel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
3:07 PM | Galera Therapeutics (Filer)
| Form 8-A12B | |
05/01/2024
4:02 PM | Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
| Form 4/A | |
04/16/2024
3:39 PM | ALPHA PHARMA Investments LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G | |
04/03/2024
7:08 AM | Altamont Pharmaceutical Holdings, LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G/A | |
04/01/2024
8:36 PM | Altamont Pharmaceutical Holdings, LLC (Reporting)
Galera Therapeutics (Issuer)
Pearson Mark E. (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
03/28/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
6:06 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
6:31 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:57 PM | Galera Therapeutics (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
| Form SC 13D/A | |
01/16/2024
5:11 PM | Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:35 AM | Galera Therapeutics (Subject)
GSA CAPITAL PARTNERS LLP (Filed by)
| Form SC 13G | |
12/04/2023
3:32 PM | Blackstone Holdings I/II GP L.L.C. (Filed by)
Galera Therapeutics (Subject)
| Form SC 13D/A | |
